跳至主要内容
临床试验/EUCTR2012-001591-11-NL
EUCTR2012-001591-11-NL进行中(未招募)不适用

Symptomatic treatment of pollen related allergic rhinoconjunctivitis and the relation with asthma with children in the General practice - HATSJOE

Erasmus MC0 个研究点开始时间: 2012年7月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Erasmus MC

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Children aged 6-18 years
  • -Recruitment in general practice based on doctor’s diagnosis AR (ICPC R97) or prescription of allergy medication (antihistamines, INCS) in the last year.
  • -Sensitization to grass pollen or grass and tree pollen (determined by CAP-RAST, class >= 2).
  • -Present symptoms of allergic rhinitis and conjunctivitis. Severity will be determined by a retrospective symptom score (patients have to recall their complaints during the previous hay fever season). Seven complaints of nose (sneezing, nose blockage, runny nose, itching nose) and eye (itching eyes, redness and tearing eyes), will be determined. Each symptom is recorded on a scale from 0 to 3. A minimum of 7 out of the maximum of 21 points is required to be included in the study.
  • -Informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 411
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Use of INCS one month prior to randomization or antihistamines one week prior to randomization
  • -Currently pregnant or breastfeeding
  • -Spending a significant amount of time abroad during the study period
  • -Not able to speak and understand the Dutch language sufficiently
  • -Not having internet access to fill in the diary and questionnaires

研究者

发起方
Erasmus MC

相似试验